Global CSF management market was valued USD 1.2 billion in 2015 and is expected to generate revenue of USD 1.6 billion by end of 2021.
The report covers detailed analysis and forecast for the CSF management market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD billion). The study includes a comprehensive view of the market with the review of market drivers, restraint, and opportunities. It also offers the level of impact of drivers and restraints on the CSF management market between 2015 and 2021.
The study included a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porter’s Five Forces model to analyze the different factors affecting the growth of the CSF management market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by product, end-user, and region.
The report includes detailed segmentation of CSF management market based on product, end-user, and region. CSF shunts are the key product in the CSF management market. On the basis of end-user segment, the market can be classified into hospitals, outpatient facilities, and other end-users. Major regional segment analyzed in this report include Asia Pacific, North America, Europe, Latin America and the Middle East & Africa with its further bifurcation into major countries including China, Japan, India, U.S. Germany, France, UK, and Brazil.
The report provides detailed competitive outlook including market share and company profiles of the key players operating in the global market. Some of the key participants in the report include B. Braun Melsungen AG, DePuy Synthes, Integra LifeSciences Holding Corporation, Codman EDS, Medtronic plc, Sophysa S.A., Spiegelberg GmbH & Co. KG, BeckerSmith Medical, Inc., and Möller Medical GmbH., among others.
This report segments the global CSF management market as follows:
Global CSF Management Market: Product Segment Analysis
Global CSF Management Market: End-user Segment Analysis
Global CSF Management Market: Regional Segment Analysis
This report is based on in-depth qualitative and quantitative analyses of the global CSF Management market. Zion Research has collected and analyzed key data belong to the global CSF Management market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of CSF Management across the world has been calculated through primary and secondary research.
Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the CSF Management industry. Primary research makes up the major source of data collection and validation.
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the CSF Management market.
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
Hydrocephalus is the swelling of brain which is caused as a result of excessive build up of cerebrospinal fluid (CSF). This excessive CSF can severely impact the patient, as it can increase intracranial pressure (ICP) which can lead to herniation, intracranial hematoma or cerebral edema. Hydrocephalus is caused due to multiple reasons such as colloid cyst, craniofacial anomalies, benign intracranial cysts, intracranial hemorrhage, choroid plexus tumor, and meningitis. CSF management plays a vital role in treatment of such number of brain and nervous system related disorders.
Increase in elderly population globally is expected to be the major driver for the global CSF management market. In addition, increasing demand for minimally invasive procedures is expected to trigger the growth of CSF management market in the coming years. Emerging economies such as India, Brazil and China are expected to offer growth opportunities for CSF management market during the forecast period. However, high cost of surgery may pose the challenge to CSF management market.
Based on product, CSF management market has been segmented into CSF drainage systems and CSF shunts. CSF management market was dominated by CSF shunts segment which accounted for largest share as CSF shunts help brain to return to a normal size by relieving the symptoms of hydrocephalus. Further it is expected to continue its dominance over the forecast period. However, risk associated with CSF shunts such as it leads to infection that is caused due to the patient’s own skin organism may affect the for growth of this segment. A CSF drainage system eliminates blood clots from intrathecal spaces, clears CSF from ventricles, and reduces the incidence of vasospasm. CSF drainage system is comparatively more accurate and cost-effective. The segment is likely to expand at the fastest growth rate during the forecast period.
The CSF management market is segmented into end-user such as hospitals, outpatient facilities, and others. In terms of revenue, the hospitals end-user segment dominated the market in 2015. At present, hospitals end-user is acting as drivers for the growth of the CSF management market. The increase in demand for 3D cell surgery across the world is creating the demand for CSF management across the globe.
In terms of region, the report segments the global CSF management market into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to remain the dominant region over the forecast period. Presence of large number of elderly population coupled along with technological advancement in this region is driving the CSF management market in North America. Asia Pacific is projected to be the fastest growing region for the CSF management market during the forecast period. The market growth in countries such as India and China as a result of increasing medical tourism and demand for minimal invasive technologies is expected to boost market in this region. Europe is expected to experience steady growth in the years to come as a result of growing elderly population in this region.
Some of the key players in B. Braun Melsungen AG, DePuy Synthes, Integra LifeSciences Holding Corporation, Codman EDS, Medtronic plc, Sophysa S.A., Spiegelberg GmbH & Co. KG, BeckerSmith Medical, Inc., and Möller Medical GmbH., among others.